XERS long swingXERS recently bounced off its 200 MA and currently has some favorable signals. The MACD is crossing and the RSI is rising but still on the cool side.
Looking at the Volume Indicator (Fixed Range) Sept 1 to Current you can see that the POC line in red (point of control) shows us that most of the trading volume has been at the current level and 70% of XERS trading volume has been in the 3.95- to 5.70 range.
Finally the price closed just under the 23% fibonacci level of 4.68
I think XERS offers a low risk entry at this level for a swing trade. First target $5.14 2nd target $5.50
This is one of my stocks to watch for 2021
0A8E trade ideas
XERS currently one of the my favorite chartsXERS has found support once again at the ascending trendline from March 2020, the trendline also coincides with the 2 VWAPs from what I would consider the significant YTD lows, as well as the very important $4.00 level.
I have been long since August ($3.54) and I am looking to add as close to $4.00 as possible because I believe the stock moves higher from here.
Xeris Pharmaceuticals, Inc 50% upside Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.
$XERS Xeris Pharma On Breakout Watch
Alert set for a break above the 200ma and $5.00 level.
Highly speculative with high Risk| Reward .
Company profile
Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
XERIS Pharma set for big moves Tuesday Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol™ and XeriJect™ formulation technologies. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Austin, TX.
XERS Sept 10th PDUFA potential run up. I bought XERS initially at 9.23 and have since then swung it from 11.50 to 12.50+ area. I believe it is heading into a short term bear trend which will precipitate a run up to the FDA PDUFA approval of it's diabetic non inject able. Short ratio is up as well.
I marked the resistance and support points that I think are major. There are no triangles to work off of only resistance and support points as well as moving averages. I will look to re-buy when i see a strong reversal from either the 9.30 or 10.50 areas. GLTA!
Hope you enjoy!